NCT06699615
Assessing Perceptions of ML Explanations by Medical Oncologists
Enrolling by Invitation
NAAll AgesInterventionalAbramson Cancer Center at Penn MedicineInvestigator-initiated
~50 participants
Updated 2026-04-06 on ClinicalTrials.gov
What's tested:Once time de-identified Qualtrics survey
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Determine whether neurosymbolic AI explainability methods improve the trustworthiness of explanations from a prognostic model, relative to post-hoc explainers.
Measured over 3 months
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Determine whether neurosymbolic AI explainability methods improve the trustworthiness of explanations from a prognostic model, relative to post-hoc explainers.3 months
Oncologist will be invited to complete a vignette-based survey